MedAll

📣 Question for HCPs: We're exploring moderate–severe obstructive sleep apnea (OSA) Is the following a gap in clinical practice? HCPs don’t consistently adapt diagnostic & referral approaches to overcome access limitations, contributing to delayed OSA diagnosis & inequitable care

📊 Healthcare professional perspectives wanted: We're exploring moderate–severe obstructive sleep apnea (OSA). Is the following a gap in clinical practice? Clinicians inconsistently apply screening tools & referral thresholds for OSA, delaying diagnosis & specialist access.

👋 Welcome to our new accredited social learning series on Biomarker-Driven Care in mCRC and NSCLC In this clip, Prof. Wainberg discusses the clinical relevance of BRAF alterations and their implications for first line treatment planning in oncology practice. Please read the accreditation and disclosures here before participating: app.medall.org/articles/first… This program is supported by an independent educational grant from Pfizer. 🇺🇸 This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country. Get access to the full series in the link above🔗

📣 Calling all U.S. HCPs involved in the care of patients with mCRC and NSCLC Listen to Prof. Wainberg explore how BRAF-associated disease patterns influence prognosis and clinical decision making in routine oncology care. Please read the accreditation and disclosures here before participating: app.medall.org/articles/first… This program is supported by an independent educational grant from Pfizer. 🇺🇸 This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country. Get access to the full series in the link above🔗

🧬 Key Updates in Biomarker-Driven Care for mCRC In this social media series Prof. Wainberg reviews how BRAF alterations are associated with distinct clinical presentation features in metastatic colorectal cancer. Please read the accreditation and disclosures here before participating: app.medall.org/articles/first… This program is supported by an independent educational grant from Pfizer. 🇺🇸 This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country. Get access to the full series in the link above🔗

🩺 Molecular Insights in mCRC and NSCLC In this clip, Prof. Wainberg discusses how understanding BRAF alterations supports multidisciplinary treatment discussions and patient management planning. Please read the accreditation and disclosures here before participating: app.medall.org/articles/first… This program is supported by an independent educational grant from Pfizer. 🇺🇸 This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country. Get access to the full series in the link above🔗

📊 Integrating Biomarker Findings into Everyday Oncology Practice In this clip, Prof. Wainberg reviews how biomarker interpretation, including BRAF alterations, informs clinical assessment and therapeutic planning in metastatic disease. Please read the accreditation and disclosures here before participating: app.medall.org/articles/first… This program is supported by an independent educational grant from Pfizer. 🇺🇸 This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country. Get access to the full series in the link above🔗

👋 Welcome to our new accredited social learning series on Thrombosis Management In this clip, MD @sidpatel2018 reviews how structured risk scores support balancing stroke prevention and bleeding risk in atrial fibrillation and acute coronary syndromes. 📚 Please read the accreditation and disclosures before participating: app.medall.org/articles/bridg… This program is supported by an independent educational grant from Bristol Myers Squibb. This online education program has been designed solely for healthcare professionals only. Get free access to the full series in the link above 🔗

📣 Involved in Thrombosis Management? Listen to Dr Patel explore how biomarkers, imaging measures, and atrial fibrillation burden are informing stroke risk assessment in clinical practice. 📚 Please read the accreditation and disclosures before participating: app.medall.org/articles/bridg… This program is supported by an independent educational grant from Bristol Myers Squibb. This online education program has been designed solely for healthcare professionals only. Get free access to the full series in the link above 🔗

🫀Key Updates in Thrombosis Management Dr. Rymer reviews how renal function and body weight influence anticoagulant dosing considerations in cardiovascular care. 📚 Please read the accreditation and disclosures before participating: app.medall.org/articles/bridg… This program is supported by an independent educational grant from Bristol Myers Squibb. This online education program has been designed solely for healthcare professionals only. Get free access to the full series in the link above 🔗

🩺 Thrombosis Management: An Accredited Social Learning Series In this clip, faculty discuss applying structured risk stratification to support antithrombotic decision making in routine clinical practice. 📚 Please read the accreditation and disclosures before participating: app.medall.org/articles/bridg… This program is supported by an independent educational grant from Bristol Myers Squibb. This online education program has been designed solely for healthcare professionals only. Get free access to the full series in the link above 🔗

Welcome to our new accredited social learning series on idiopathic pulmonary fibrosis (IPF). Please read the accreditation and disclosures here before participating: app.medall.org/articles/pulmo… Supported by an independent educational grant from Bristol Myers Squibb and delivered in joint providership with CCI. In this clip, Prof. Corey Kershaw clarifies what truly defines idiopathic pulmonary fibrosis (IPF). • IPF requires a UIP pattern on HRCT or histology and the absence of an identifiable cause, including environmental exposures, drug toxicity, or connective tissue disease. • IPF is a diagnosis of exclusion, not a CT finding alone. Get access to the full series in the link above.

🎥 Listen to Prof. Corey Kershaw discussing guidelines for interpreting HRCT in suspected IPF in this part of our ongoing micro-learning series on interstitial lung disease and pulmonary fibrosis. Please read the accreditation and disclosures here before participating: app.medall.org/articles/pulmo… Supported by an independent educational grant from Bristol Myers Squibb and delivered in joint providership with CCI. Get access to the full series in the link above

Explore Emerging therapeutic targets in pulmonary fibrosis as part of our ongoing micro-learning series on interstitial lung disease and pulmonary fibrosis. Please read the accreditation and disclosures here before participating: app.medall.org/articles/pulmo… Supported by an independent educational grant from Bristol Myers Squibb and delivered in joint providership with CCI. Get access to the full series in the link above.